Risk of secondary malignancies in ovarian cancer survivors: 52,680 patients analyzed with over 40 years of follow-up

CONCLUSIONS: This is the largest study to examine the risk of SM in patients with ovarian cancer and has the longest follow-up. Risk of SM was increased after ovarian cancer and varied with treatment modality, race, latency, and age. These results may help inform SM screening protocols for women diagnosed with ovarian cancer.PMID:34092413 | DOI:10.1016/j.ygyno.2021.05.034

Source: Gynecologic Oncology - June 7, 2021 Category: Cancer & Oncology Authors: Anthony C Casper Matthew W Parsons Jonathan Chipman Lindsay M Burt Gita Suneja Kathryn A Maurer David K Gaffney Source Type: research